Search
RAP-103
go.drugbank.com/drugs/DB28444ExperimentalRAP-103 is a multi-chemokine receptor antagonist which is orally active.[A274606, A274611]
MEM 1003
go.drugbank.com/drugs/DB05547InvestigationalMEM 10003 was under investigation in clinical trial NCT00257673 (Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease) for the treatment of Alzheimer's Disease
ST-101
go.drugbank.com/drugs/DB12621InvestigationalST-101 is a small peptide antagonist of C/EBPβ and T-type calcium channel activator. ST101 has been used in trials studying the treatment of Essential Tremor and Alzheimer's Disease.[A260411]
Synonyms: ST-101 (D-AMINO ACID PEPTIDE)CB-103
go.drugbank.com/drugs/DB15279InvestigationalCB-103 is under investigation in clinical trial NCT03422679 (Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies).
Salts: CB-103 hydrochlorideTSHA-102
go.drugbank.com/drugs/DB18599InvestigationalTSHA-102 is a recombinant serotype 9 adeno-associated virus encoding a codon-optimized human MECP2 gene.
KAHR-102
go.drugbank.com/drugs/DB17427InvestigationalKAHR-102 is a dual signaling protein fusing cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) to the Fas-ligand (FasL).
TERN-101
go.drugbank.com/drugs/DB16045InvestigationalTERN-101 is under investigation in clinical trial NCT04328077 (LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-cirrhotic Non-alcoholic Steatohepatitis
Imidapril
go.drugbank.com/drugs/DB11783InvestigationalImidapril has been investigated for the treatment of Kidney, Polycystic, Autosomal Dominant.
Products: TANATRIL TABLETS 10 mg, TANATRIL TABLETS 5 mgDexrabeprazole
go.drugbank.com/drugs/DB13762InvestigationalMixtures: DEXRIDON MR 30/10 MG KAPSÜL ,30 KAPSÜLCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C19 SubstratesImidafenacin
go.drugbank.com/drugs/DB09262InvestigationalImidafenacin is an antispasmodic agent with anticholinergic effects. It antagonizes muscarinic receptors in the bladder to reduce the frequency of urination in the treatment of overactive bladder. It is marketed in Japan under the traden...
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesProducts: URITOS (TABLETS 0.1 MG), URITOS TABLETS 0.1 MG